Michael R. Yeaman

21.4k total citations · 1 hit paper
195 papers, 15.0k citations indexed

About

Michael R. Yeaman is a scholar working on Infectious Diseases, Molecular Biology and Microbiology. According to data from OpenAlex, Michael R. Yeaman has authored 195 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Infectious Diseases, 78 papers in Molecular Biology and 56 papers in Microbiology. Recurrent topics in Michael R. Yeaman's work include Antimicrobial Resistance in Staphylococcus (93 papers), Antimicrobial Peptides and Activities (54 papers) and Streptococcal Infections and Treatments (45 papers). Michael R. Yeaman is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (93 papers), Antimicrobial Peptides and Activities (54 papers) and Streptococcal Infections and Treatments (45 papers). Michael R. Yeaman collaborates with scholars based in United States, Germany and Switzerland. Michael R. Yeaman's co-authors include Nannette Y. Yount, Arnold S. Bayer, Scott G. Filler, Yan Q. Xiong, Ambrose L. Cheung, John E. Edwards, Michael E. Selsted, Cynthia C. Nast, Ashraf S. Ibrahim and Soo‐Jin Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Michael R. Yeaman

193 papers receiving 14.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Antimicrobial Peptide Action and Resistance

2003 2.5k citations Michael R. Yeaman, Nannette Y. Yount profile →

Peers

Countries citing papers authored by Michael R. Yeaman

Since Specialization

Citations

This map shows the geographic impact of Michael R. Yeaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Yeaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Yeaman more than expected).

Fields of papers citing papers by Michael R. Yeaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Yeaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Yeaman. The network helps show where Michael R. Yeaman may publish in the future.

Co-authorship network of co-authors of Michael R. Yeaman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Yeaman. A scholar is included among the top collaborators of Michael R. Yeaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Yeaman. Michael R. Yeaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia 2025 ·BMC Infectious Diseases ·(unknown), Ying Zheng, Maura Rossetti, Felicia Ruffin, Harry Pickering, (unknown), Gemalene Sunga, Liana C. Chan, David W. Gjertson, Vance G. Fowler, Michael R. Yeaman, Elaine F. Reed, (unknown), (unknown), Felix Mba Medie, (unknown), Joshua T. Thaden	0
2	Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysin 2024 ·Nature Microbiology ·Jianfeng Lin, Jian Miao, (unknown), C. Russell, (unknown), Fuming Zhang, Quynh T. Phan, Norma V. Solis, Hong Liu, Masato Tashiro, Jonathan S. Dordick, Robert J. Linhardt, Michael R. Yeaman, Gavin M. King, Francisco N. Barrera, Brian M. Peters, Scott G. Filler	6
3	Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis 2024 ·Neurology Neuroimmunology & Neuroinflammation ·Giulio Volpe, Neringa Jurkutė, (unknown), Hanna Zimmermann, Seyedamirhosein Motamedi, (unknown), Lekha Pandit, Anitha D’Cunha, Michael R. Yeaman, Terry J. Smith, Lawrence J. Cook, Alexander U. Brandt, Friedemann Paul, Axel Petzold, Frederike Cosima Oertel	1
4	The Archetypal Gamma-Core Motif of Antimicrobial Cys-Rich Peptides Inhibits H+-ATPases in Target Pathogens 2024 ·International Journal of Molecular Sciences ·María Teresa Ainaga Andrés, Nannette Y. Yount, Maikel Acosta‐Zaldívar, Michael R. Yeaman, José F. Fierro	1
5	Integrated transcriptomic analysis reveals T and B cell immune signatures influencing resolving outcome in MRSA bacteremia 2023 ·The Journal of Immunology ·Rajesh Parmar, Harry Pickering, David W. Gjertson, Liana C. Chan, Michael R. Yeaman, Elaine F. Reed	1
6	Tensor-based insights into systems immunity and infectious disease 2023 ·Trends in Immunology ·(unknown), Liana C. Chan, Michael R. Yeaman, Aaron S. Meyer	5
7	Mathematical models to study the biology of pathogens and the infectious diseases they cause 2022 ·iScience ·João B. Xavier, Jonathan M. Monk, Saugat Poudel, Charles J. Norsigian, Anand V. Sastry, Chen Liao, José Maurício S. Bento, Marc A. Suchard, Mario L. Arrieta‐Ortiz, Eliza J. R. Peterson, Nitin S. Baliga, Thomas Stoeger, Felicia Ruffin, (unknown), Catherine A. Gao, Thomas D. Horvath, Anthony M. Haag, Qinglong Wu, Tor Savidge, Michael R. Yeaman	11
8	Impacts of NaHCO3 on β-Lactam Binding to PBP2a Protein Variants Associated with the NaHCO3-Responsive versus NaHCO3-Non-Responsive Phenotypes 2022 ·Antibiotics ·Selvi C. Ersoy, Liana C. Chan, Michael R. Yeaman, Henry F. Chambers, Richard A. Proctor, Kevin C. Ludwig, Tanja Schneider, Adhar C. Manna, Ambrose L. Cheung, Arnold S. Bayer	7
9	Efficacy and safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD): Results from open-label extension periods of SAkuraSky and SAkuraStar 2021 ·Investigative Ophthalmology & Visual Science ·Zdenka Hašková, Benjamin Greenberg, Jeffrey L. Bennett, Brian G. Weinshenker, Anthony Traboulsee, Michael R. Yeaman, Kristina Weber, Kathleen Blondeau, H.‐Christian von Büdingen, Daniela Stokmaier, Gaëlle Klingelschmitt	1
10	Platelet Deficiency Represents a Modifiable Risk Factor for Periprosthetic Joint Infection in a Preclinical Mouse Model 2021 ·Journal of Bone and Joint Surgery ·(unknown), (unknown), (unknown), Nicolas Cevallos, Benjamin V. Kelley, Zeinab Mamouei, Michael R. Yeaman, Nicholas M. Bernthal	6
11	Identification of Candida glabrata Transcriptional Regulators That Govern Stress Resistance and Virulence 2020 ·Infection and Immunity ·(unknown), Yaoping Liu, Norma V. Solis, Ling Wang, (unknown), John E. Edwards, Scott G. Filler, Michael R. Yeaman	11
12	Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience 2020 ·Multiple Sclerosis and Related Disorders ·Wenjuan Huang, Jingzi ZhangBao, (unknown), Liang Wang, Chongbo Zhao, Jiahong Lu, Min Wang, Xiaoyan Ding, Yafang Xu, Lei Zhou, Dingguo Li, (unknown), Jacinta M. Behne, Michael R. Yeaman, Eliezer Katz, Chuanzhen Lü, Chao Quan	28
13	The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection 2018 ·PLoS Pathogens ·Priya Uppuluri, Lin Lin, Abdullah Alqarihi, Guanpingsheng Luo, Eman G. Youssef, Sondus Alkhazraji, Nannette Y. Yount, (unknown), Michael Bolaris, John E. Edwards, Marc Swidergall, Scott G. Filler, Michael R. Yeaman, Ashraf S. Ibrahim	39
14	Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus 2015 ·Infection and Immunity ·Liana C. Chan, (unknown), Scott G. Filler, (unknown), Huiyuan Wang, Deborah Kupferwasser, John E. Edwards, Yan Q. Xiong, Ashraf S. Ibrahim, Lloyd Miller, Clint S. Schmidt, John P. Hennessey, Michael R. Yeaman	44
15	Role of the LytSR Two-Component Regulatory System in Adaptation to Cationic Antimicrobial Peptides in Staphylococcus aureus 2013 ·Antimicrobial Agents and Chemotherapy ·Soo‐Jin Yang, Yan Q. Xiong, Michael R. Yeaman, Kenneth W. Bayles, Wessam Abdelhady, Arnold S. Bayer	33
16	The RpoB H481Y Rifampicin Resistance Mutation and an Active Stringent Response Reduce Virulence and Increase Resistance to Innate Immune Responses in Staphylococcus aureus 2012 ·The Journal of Infectious Diseases ·Wei Gao, David R. Cameron, John K. Davies, Xenia Kostoulias, (unknown), Kellie L. Tuck, Michael R. Yeaman, Anton Y. Peleg, Timothy P. Stinear, Benjamin P. Howden	78
17	The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus 2008 ·Infection and Immunity ·Brad Spellberg, Ashraf S. Ibrahim, Michael R. Yeaman, Lin Lin, Yue Fu, Valentina Avanesian, Arnold S. Bayer, Scott G. Filler, Peter N. Lipke, Henry N. Otoo, John E. Edwards	123
18	Als3 Is a Candida albicans Invasin That Binds to Cadherins and Induces Endocytosis by Host Cells 2007 ·PLoS Biology ·Quynh T. Phan, Carter L. Myers, Yue Fu, Donald C. Sheppard, Michael R. Yeaman, William H. Welch, Ashraf S. Ibrahim, John E. Edwards, Scott G. Filler	464
19	Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus 2003 ·Journal of Clinical Investigation ·Leon Iri Kupferwasser, Michael R. Yeaman, Cynthia C. Nast, Deborah Kupferwasser, Yan-Qiong Xiong, Marco Palma, Ambrose L. Cheung, Arnold S. Bayer	120
20	Diminished Virulence Of A Sar-lagr- Mutant Of Staphylococcus Aureus In The Rabbit Model Of Endocarditis 1994 ·Scopus ·A L Cheung, (unknown), (unknown), Michael R. Yeaman, Paul M. Sullam, Marcelo de Carvalho Ramos, Arnold S. Bayer	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact